Multiple Sclerosis :: Living with fatigue – a new MS Trust book
The latest book from the MS Trust aims to give people with MS a better understanding of the causes of fatigue and offers some practical suggestions for managing the symptom.
People
Health :: Incentive-Based Therapy Improves Outlook For Methamphetamine Abusers
New research suggests that offering methamphetamine abusers an incentive-based behavioral therapy program called contingency management (CM ? also known as Motivational Incentives), along with psychosocial therapy is more effective than psychosocial therapy alone. The study was supported by the National Institute on Drug Abuse (NIDA), National Institutes of Health, and is published in the November 2006 issue of the American Journal of Psychiatry.
Immunity :: Natural compounds block autoimmune response in diabetes, arthritis
Natural compounds derived from a sea anemone extract and a shrub plant have been found to block the autoimmune disease response in type-1 diabetes and rheumatoid arthritis, according to University of California, Irvine researchers.
Cancer :: ‘Hair Again’ Gives Cancer Journey Meaning
“Medicine alone is not enough to get you through cancer,” comments Linda Dibblee, breast cancer survivor and winner of the 2006 Lilly Oncology on Canvas International Art Competition and Exhibition. “You have to stay strong and positive through even the darkest times. Having a channel through which you can release your feelings can help you find strength that you never knew you had. For me, painting became my way of expressing all my thoughts, hopes and frustrations, and I truly believe it played a part in helping me beat cancer.”
Diabetes :: Accurate coding is key to preventing potentially serious health complications associated with insulin overdose
Significant errors in insulin dose can result when blood glucose meters are miscoded according to new clinical study. When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications, according to findings of a new study presented at the Sixth Annual Diabetes Technology Meeting in Atlanta, Georgia.
Colorectal Cancer :: Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
ImClone Systems Incorporated (NASDAQ:IMCL) and Bristol-Myers Squibb Company (NYSE:BMY) today announced results from two randomized Phase III trials of ERBITUX(R) (cetuximab) in patients with metastatic colorectal cancer. These are the first large, randomized studies to examine the impact of ERBITUX treatment on overall survival in colon cancer.
Osteoarthritis :: Prexige in the European Union as a new treatment option for osteoarthritic pain
Novartis announced today that Prexige? (lumiracoxib), an oral selective COX-2 inhibitor anti-inflammatory drug, has been cleared for approval in the European Union as a new treatment option for patients suffering from osteoarthritis. This is the most common form of arthritis and a leading cause of chronic pain[2].
Health Care :: Novartis creates new strategic biomedical R&D center in Shanghai
Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai’s Zhangjiang Hi-Tech Park that will become an integral part of the Group’s global research and development network.
Health :: FDA issues approvable letter for Entereg for POI
GlaxoSmithKline (NYSE: GSK) and Adolor Corporation (Nasdaq: ADLR) announced that the Food and Drug Administration (FDA) has issued a letter stating that the new drug application (NDA) for Entereg (alvimopan 12mg) for the management of post operative ileus (POI) is approvable. The FDA has requested 12-month safety data, including analysis of serious cardiovascular events, from study 014 (767905/014), an ongoing safety study in opioid-induced bowel dysfunction (OBD). The FDA also requested a risk management plan as part of the submission.
Anxiety :: FSU study links anxiety sensitivity to future psychological disorders
People who experience a pounding heart, sweaty palms or dizziness — even if the cause is something as mundane as stress, exercise or caffeine — are more likely to develop a clinical case of anxiety or panic disorder, according to a Florida State University researcher in Tallahassee, Fla.